Item type | Home library | Collection | Class number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|
UNKNOWN | Ferriman information and Library Service (North Middlesex) Online | Staff publications for NMDX | Available |
NMUH Staff Publications
3
<h4 style="font-size: 13px; margin: 0px 0.25em 0px 0px; text-transform: uppercase; float: left; font-family: arial, helvetica, clean, sans-serif; line-height: 17.9998016357422px;"><span style="font-size: 8pt;"><span style="font-family: Arial;">BACKGROUND:</span></span></h4><p style="margin: 0px 0px 0.5em; font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998016357422px;"><span style="font-size: 8pt;"><span style="font-family: Arial;">The&nbsp;<span class="highlight">diagnosis</span>&nbsp;and&nbsp;<span class="highlight">staging</span>&nbsp;of&nbsp;<span class="highlight">lung</span>&nbsp;<span class="highlight">cancer</span>&nbsp;is an important process that identifies treatment options and guides disease prognosis. We aimed to assess&nbsp;<span class="highlight">endobronchial</span>&nbsp;<span class="highlight">ultrasound-guided</span>&nbsp;<span class="highlight">transbronchial</span>&nbsp;<span class="highlight">needle</span>&nbsp;<span class="highlight">aspiration</span>&nbsp;as an initial investigation technique for patients with suspected<span class="highlight">lung</span>&nbsp;<span class="highlight">cancer</span>.</span></span></p><h4 style="font-size: 13px; margin: 0px 0.25em 0px 0px; text-transform: uppercase; float: left; font-family: arial, helvetica, clean, sans-serif; line-height: 17.9998016357422px;"><span style="font-size: 8pt;"><span style="font-family: Arial;">METHODS:</span></span></h4><p style="margin: 0px 0px 0.5em; font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998016357422px;"><span style="font-size: 8pt;"><span style="font-family: Arial;">In this&nbsp;<span class="highlight">open-label</span>, multicentre,&nbsp;<span class="highlight">pragmatic</span>,&nbsp;<span class="highlight">randomised</span>&nbsp;<span class="highlight">controlled</span>&nbsp;<span class="highlight">trial</span>, we recruited patients who had undergone a CT scan and had suspected stage I to IIIA&nbsp;<span class="highlight">lung</span>&nbsp;<span class="highlight">cancer</span>, from six UK centres and randomly assigned them to either&nbsp;<span class="highlight">endobronchial</span>&nbsp;<span class="highlight">ultrasound-guided</span>&nbsp;<span class="highlight">transbronchial</span><span class="highlight">needle</span>&nbsp;<span class="highlight">aspiration</span>&nbsp;(EBUS-TBNA) or&nbsp;<span class="highlight">conventional</span>&nbsp;<span class="highlight">diagnosis</span>&nbsp;and&nbsp;<span class="highlight">staging</span>&nbsp;(CDS), for further investigation and&nbsp;<span class="highlight">staging</span>. If a target node could not be accessed by EBUS-TBNA, then endoscopic&nbsp;<span class="highlight">ultrasound-guided</span>&nbsp;fine&nbsp;<span class="highlight">needle</span>&nbsp;<span class="highlight">aspiration</span>&nbsp;(EUS-FNA) was allowed as an alternative procedure. Randomisation was stratified according to the presence of mediastinal lymph nodes measuring 1 cm or more in the short axis and by recruiting centre. We used a telephone randomisation method with permuted blocks of four generated by a computer. Because of the nature of the intervention, masking of participants and consenting investigators was not possible. The primary endpoint was the time-to-treatment decision after completion of the diagnostic and&nbsp;<span class="highlight">staging</span>&nbsp;investigations and analysis was by intention-to-diagnose. This&nbsp;<span class="highlight">trial</span>&nbsp;is registered with ClinicalTrials.gov, number<a href="http://clinicaltrials.gov/show/NCT00652769" title="See in ClincalTrials.gov" style="border-bottom-width: 0px;">NCT00652769</a>.</span></span></p><h4 style="font-size: 13px; margin: 0px 0.25em 0px 0px; text-transform: uppercase; float: left; font-family: arial, helvetica, clean, sans-serif; line-height: 17.9998016357422px;"><span style="font-size: 8pt;"><span style="font-family: Arial;">FINDINGS:</span></span></h4><p style="margin: 0px 0px 0.5em; font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998016357422px;"><span style="font-size: 8pt;"><span style="font-family: Arial;">Between June 10, 2008, and July 4, 2011, we randomly allocated 133 patients to treatment: 66 to EBUS-TBNA and 67 to CDS (one later withdrew consent). Two patients from the EBUS-TBNA group underwent EUS-FNA. The median time to treatment decision was shorter with EBUS-TBNA (14 days; 95% CI 14-15) than with CDS (29 days; 23-35) resulting in a hazard ratio of 1·98, (1·39-2·82, p&lt;0·0001). One patient in each group had a pneumothorax from a CT-guided biopsy sample; the patient from the CDS group needed intercostal drainage and was admitted to hospital.</span></span></p><h4 style="font-size: 13px; margin: 0px 0.25em 0px 0px; text-transform: uppercase; float: left; font-family: arial, helvetica, clean, sans-serif; line-height: 17.9998016357422px;"><span style="font-size: 8pt;"><span style="font-family: Arial;">INTERPRETATION:</span></span></h4><p style="margin: 0px 0px 0.5em; font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998016357422px;"><span style="font-family: Arial;"><span style="font-size: 8pt;"><span class="highlight">Transbronchial</span>&nbsp;<span class="highlight">needle</span>&nbsp;<span class="highlight">aspiration</span>&nbsp;guided by&nbsp;<span class="highlight">endobronchial</span>&nbsp;ultrasound should be considered as the initial investigation for patients with suspected&nbsp;<span class="highlight">lung</span>&nbsp;<span class="highlight">cancer</span>, because it reduces the time to treatment decision&nbsp;<span class="highlight">compared</span>&nbsp;with&nbsp;<span class="highlight">conventional</span>&nbsp;<span class="highlight">diagnosis</span>&nbsp;and&nbsp;<span class="highlight">staging</span>techniques.</span></span></p>
There are no comments on this title.